Skip to main content

Table 1 Characteristics of liposomal formulations (Mean ± SD, n = 3)

From: Ternary nanocomposite carriers based on organic clay-lipid vesicles as an effective colon-targeted drug delivery system: preparation and in vitro/in vivo characterization

Formulation

Size (nm)

PDI

Zeta potential (mV)

Encapsulation efficiency (%)

Bud-Lip

117 ± 10

0.42 ± 0.02

− 21.4 ± 0.7

95.6 ± 1.7

AC-Bud-Lip

194 ± 12

0.25 ± 0.11

7.0 ± 2.9

74.7 ± 7.6

EAC-Bud-Lip

321 ± 18

0.40 ± 0.12

− 12.8 ± 5.8

82.7 ± 9.8